ClinicalTrials.gg
Sign In

Nephrotic Syndrome clinical trials

The registry lists 191 studies for Nephrotic Syndrome across more than 10 countries. 65 are recruiting or about to start. 127 of them are mainly about Nephrotic Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Nephrotic Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
84
Recruiting
50
Status unknown
18
Not yet recruiting
14
Terminated
9
Withdrawn
7

Phase

Phase 2
43
Phase 3
33
Phase 4
23
Phase 1
13
Early Phase 1
5

Where

United States
51
China
34
Italy
21
France
16
Egypt
10
Canada
6

Who runs them

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (11) · The Children's Hospital of Zhejiang University School of Medicine (11) · Assistance Publique - Hôpitaux de Paris (9) · Istituto Giannina Gaslini (7) · Mario Negri Institute for Pharmacological Research (6) · University of Michigan (5) · Children's Hospital of Fudan University (5) · Assiut University (4)

What is being tested here

Drugs under test in Nephrotic Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rituximab4918
Cyclosporine202
Adrenocorticotropic Hormone128
Dapagliflozin112
Zuberitamab111
RD06-05101
Edoxaban101
Belimumab101
TACI receptor-IgG Fc fragment fusion protein101
Empagliflozin111

Drug classes tested here Calcineurin inhibitors 2 open · Factor Xa inhibitors 1 open · Corticosteroids 6 · Statins 3

Coming up

10phase 3 studies under way
10studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 50 Nephrotic Syndrome studies recruiting now, 23 (46%) set no upper age limit and 22 (44%) stop at 75 or younger. 37 (74%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (8%) take healthy volunteers.

Recruiting studies that take each age, of 50
AgeWomenMen
1034 (68%)34 (68%)
1843 (86%)43 (86%)
3035 (70%)35 (70%)
4034 (68%)34 (68%)
5033 (66%)33 (66%)
6533 (66%)33 (66%)
7533 (66%)33 (66%)
8526 (52%)26 (52%)

Across all 191 studies, recruiting or not: 59% stop at 75 or younger and 51% at 65; 68% take children; 0% are for women only and 0% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 191. Browse all 191 → or search them.